JAMA & ARCHIVES
JAMA & Archives
SEARCH
GO TO ADVANCED SEARCH
HOME  EMBARGOED CONTENT  PAST ISSUES  EVENTS  HELP  SEARCH RELEASES


October 26, 2004

JAMA news releases are made available to the public after 3 pm US Central time on the first 4 Tuesdays of each month. The Archives Journals news releases are made available to the public after 3 pm Central time on Mondays. We also provide a list of previous news releases.

THIS WEEK'S CONTENT

JAMA NEWS RELEASES
(Embargoed for Release: 3 p.m. CT, Tuesday, October 26, 2004)


JAMA NEWS RELEASES

>   USE OF STOMACH ACID-SUPPRESSIVE MEDICATIONS ASSOCIATED WITH INCREASED RISK OF PNEUMONIA

>   COMBINATION THERAPY, NOT MEDICATION ALONE, MOST EFFECTIVE FOR TREATING CHILDREN AND ADOLESCENTS WITH OCD

>   APPENDIX RUPTURE IN CHILDREN ASSOCIATED WITH RACE AND HEALTH INSURANCE STATUS


INFORMATION CONTAINED IN THESE NEWS RELEASES IS PROTECTED BY COPYRIGHT. JOURNAL ATTRIBUTION IS REQUIRED.

TV Note: This week's JAMA video news release is on the most effective treatments for children and adolescents with obsessive-compulsive disorder. The release will be fed Tuesday, October 26, from 9:00 - 9:30 a.m. ET on Intelsat America 6 (formerly Telstar 6), Transponder 11 (C-Band) and from 2:00 - 2:30 p.m. ET on Intelsat America 6, Transponder 11 (C-Band). For more information, call 312/464-JAMA (5262).

Please Note: Our e-mail has changed to mediarelations{at}jama-archives.org

JOURNALISTS CAN NOW ACCESS EMBARGOED JAMA/ARCHIVES STUDIES ONLINE

Go to www.jamamedia.org for more information and to apply for access.

Please Note: The FOR THE MEDIA Web site now has a search feature to enable media to find previous JAMA/Archives news releases on specific medical topics. This search feature link is located on the home page at www.jamamedia.org

Please Note: In this issue of JAMA there are commentaries by Presidential candidates John Kerry and George W. Bush on their plans to ensure access to health care. The commentaries will posted at www.jama.com at 3 p.m. CT Tuesday, Oct. 26.

Embargoed for Release: 3 p.m. CT, TUESDAY, October 26, 2004
Media Advisory: To contact Robert J.F. Laheij, Ph.D., email: r.laheij{at}mdl.umcn.nl. To contact editorialist James C. Gregor, M.D., call Debbie Neufert at 519-685-8500, ext. 74772.

USE OF STOMACH ACID-SUPPRESSIVE MEDICATIONS ASSOCIATED WITH INCREASED RISK OF PNEUMONIA

CHICAGO—Individuals who use gastric acid-suppressive medications may be at an elevated risk of developing community-acquired pneumonia, according to an article in the October 27 issue of JAMA.

According to background information in the article, 20 to 40 percent of the general population experiences at least one episode of indigestion or gastroesophageal reflux disease (GERD, a backflow of acid from the stomach into the swallowing tube or esophagus) and five percent consult a general practitioner for their ailment. In primary care, a common way to treat these symptoms is to reduce gastric (stomach) acid secretions with the use of acid-suppressive drugs. However, these medications can increase vulnerability to infections, as stomach acidity is a major defense mechanism against ingested pathogens.

Robert J.F. Laheij, Ph.D., from the University Medical Center St. Radboud, Nijmegen, Netherlands, and colleagues studied pneumonia rates of both patients who did and did not use acid-suppressing medication. Patients were identified from the Integrated Primary Care Information (IPCI) database between January 1995 and December 2002. The study population included 364,683 individuals from the Netherlands who developed 5,551 cases of pneumonia for the first time.

The researchers found that current use of all acid-suppressive drugs was associated with a 27 percent increase in the risk of pneumonia, with higher risks for specific classes of acid-suppressive drugs (such as proton pump inhibitors or H2-receptor antagonist drugs).

"The effectiveness of acid-suppressive drugs in the treatment of upper gastrointestinal tract symptoms is excellent. Acid-suppressive drugs nevertheless seem to have some significant drawbacks," write the authors. "Persons using acid-suppressive drugs more often develop a community-acquired pneumonia compared with those who do not use acid-suppressive drugs, which is in general not a problem because the risk for developing pneumonia is low. The increased risk for pneumonia is a problem for patients who are at increased risk for infection, especially because community-acquired pneumonia is potentially dangerous."
(
JAMA. 2004;292:1955-1960. Available post-embargo at jama.com)

EDITORIAL: ACID SUPPRESSION AND PNEUMONIA - A CLINICAL INDICATION FOR RATIONAL PRESCRIBING

In an accompanying editorial, James C. Gregor, M.D., from the University of Western Ontario, London, Ontario, Canada, examines the effectiveness and risks of acid-suppressive drugs.

"Because of their efficacy and impressive safety profile that has far exceeded original expectations, acid-suppressing drugs have consistently been among the most widely prescribed medications worldwide, with almost $13 billion in sales in 1998 and an annual growth rate of three percent."

Dr. Gregor states that these drugs are now widely used to treat a number of gastrointestinal diseases. "As the indications for these drugs expand further and as the population ages, the number of patient-years of exposure will continue to increase and any unrecognized complications will become of greater importance."

He concludes by saying: "If acid suppression causes some cases of pneumonia, it is reassuring that the risk is relatively small and that the complication in most cases is usually amenable to therapy. However, no medication is without potential adverse effects. Concerns for patient safety should guide initial prescribing and perhaps more importantly, chronic use of even the most apparently benign drug."
(JAMA. 2004;292:2012-2013. Available post-embargo at jama.com)

For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org (please note new email address).

Go back to the top.


Embargoed for Release: 3 p.m. CT, TUESDAY, October 26, 2004
Media Advisory: To contact John S. March, M.D., M.P.H., call Tracey Koepke at 919-660-1301.

COMBINATION THERAPY, NOT MEDICATION ALONE, MOST EFFECTIVE FOR TREATING CHILDREN AND ADOLESCENTS WITH OCD

CHICAGO—Treating children and adolescents with obsessive-compulsive disorder (OCD) with a combination of cognitive-behavior therapy (CBT) and the medication sertraline is more effective than CBT or sertraline alone, according to a study in the October 27 issue of JAMA.

Epidemiologic data suggest that approximately 1 in 200 young people suffers from OCD, which in many cases severely disrupts academic, social, and vocational functioning, according to background information in the article. Among adults with OCD, one-third to one-half develop the disorder during childhood or adolescence, which suggests that early intervention in childhood may prevent long-term illness in adulthood. Previous research has shown the effectiveness of short-term CBT or medical management with a selective serotonin reuptake inhibitor (such as sertraline, an antidepressant). However, little is known about their relative and combined efficacy. CBT is a form of psychotherapy that helps patients change their thought patterns and behaviors related to obsessive thoughts and compulsions.

OCD is characterized by recurrent obsessions and/or compulsions that are intense enough to cause severe discomfort. Obsessions are recurrent and persistent thoughts, impulses, or images that are unwanted and cause marked anxiety or distress. Compulsions are repetitive behaviors or rituals (such as hand washing, hoarding, checking something over and over) or mental acts (such as counting, repeating words silently).

John S. March, M.D., M.P.H., of the Duke University Medical Center, Durham, N.C., and members of the Pediatric OCD Treatment Study (POTS) team, evaluated the efficacy of CBT alone, medication management with the SSRI sertraline alone, or combined treatment consisting of CBT and sertraline as initial treatment for children and adolescents with OCD. POTS, a randomized controlled trial, was conducted at three academic centers in the U.S. and included 112 patients aged 7 through 17 years with a diagnosis of OCD. Patients were recruited between September 1997 and December 2002. Participants were randomly assigned to receive CBT alone, sertraline alone, combined CBT and sertraline, or pill placebo for 12 weeks.

Ninety-seven of 112 patients (87 percent) completed the full 12 weeks of treatment. The researchers found that "patients treated with CBT either alone or in combination with medication showed a substantially higher probability of improvement, with the edge going to combination treatment over CBT alone in one site but not in the other. Sertraline alone proved statistically superior to placebo, confirming the efficacy of medication used to treat OCD in youth; however, the effect size of CBT alone was larger than that for sertraline alone, and more patients receiving CBT alone entered remission than did those receiving sertraline alone (39.3 percent vs. 21.4 percent, respectively), though these differences did not reach statistical significance. Thus, we conclude that children and adolescents with OCD should begin treatment with CBT alone or with CBT plus an SSRI."

The three active treatments proved acceptable and well tolerated, with no evidence of treatment-emergent harm to self or to others.

"...the POTS carries significant public health implications for the management of OCD in youth and for future directions in research. Pediatric OCD is a common, chronic, and often undiagnosed psychiatric disorder that, if not adequately treated, is associated with considerable morbidity extending into adulthood. As illustrated by the fact that the overwhelming majority of POTS patients completed treatment as intended using treatment protocols intended for use by frontline clinicians, POTS treatments are both acceptable and practical in routine clinical practice," the authors write.
(
JAMA. 2004;292:1969-1976. Available post-embargo at jama.com)

Editor's Note: The Pediatric OCD Treatment Study was supported by a NIMH grant. Sertraline and matching placebo were provided to the POTS under an independent educational grant from Pfizer Inc. to Dr. March. Dr. March has received speaker fees from Pfizer, consulting fees from Pfizer and Wyeth, and research support from Pfizer and Lilly, and has served as a scientific advisor for Pfizer and on the data safety and monitoring board for Organon, Astra-Zeneca, and Pfizer. Co-author Dr. Rynn has served as a consultant and speaker for Pfizer and as a consultant for Wyeth and Lilly.

For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org

Go back to the top.


Embargoed for Release: 3 p.m. CT, TUESDAY, October 26, 2004
Media Advisory: To contact corresponding author Kurt D. Newman, M.D., call Emily Dammeyer at 202-884-4500.

APPENDIX RUPTURE IN CHILDREN ASSOCIATED WITH RACE AND HEALTH INSURANCE STATUS

CHICAGO—Asian children and black children experience higher rates of ruptured appendixes than white children, as do uninsured or Medicaid-insured children, compared to children covered by private insurance, according to a study in the October 27 issue of JAMA. The rate of "negative appendectomy" (appendix removal without appendicitis) declines at hospitals that perform more appendectomies.

According to background information in the article, the primary adverse outcome of appendicitis is appendiceal (appendix) rupture. Patients with a ruptured appendix at the time of surgical exploration have as high as a 39 percent chance of having a postsurgical complication, such as intra-abdominal abscess or wound infection, compared with an approximately 8 percent chance if the appendix is not perforated. It has been assumed that the natural history of appendix rupture is within the control of the hospital or physician and that a high rate of rupture reflects a failure of medical care.

Given the difficulty of diagnosing appendicitis in both children and adults, the traditional approach by hospitals to decrease the rupture rate has been to encourage early surgical exploration. In fact, high rates of negative exploration for appendicitis have been tolerated to lessen the likelihood of ruptured appendicitis and its complications. In essence, one complication (a negative exploration) is encouraged to decrease the incidence of another complication (appendiceal rupture). Rates for both of these in children remain high despite efforts to reduce them. Little is known about the factors that influence these rates.

Todd A. Ponsky, M.D., of Children's National Medical Center and George Washington University Medical Center, Washington, D.C., and colleagues examined the patterns of diagnosis and care of children aged 5 to 17 years with appendicitis at 36 major children's hospitals to assess the contributions of race, health insurance status, age, sex, and hospital volume on the ruptured appendicitis rate. They also evaluated the correlation between rupture rate and negative appendectomy rate (surgical removal of a nondiseased appendix). The researchers reviewed a database containing information on 24,411 appendectomies performed on children in the United States between 1997 and 2002.

The researchers found that the average negative appendectomy rate was 3 percent and the average appendix rupture rate was 35 percent. The rupture rate was 66 percent higher in Asian children and 13 percent higher in black children compared with white children. Children without health insurance had a 36 percent increased likelihood for an appendix rupture and children with Medicaid insurance had a 48 percent increased likelihood compared with children who had private health insurance. No correlation existed between negative appendectomy rate and race, health insurance status, or hospital appendiceal rupture rate. The negative appendectomy rate improved as the hospital appendectomy volume increased.

"These findings present a dual challenge for improving the outcomes of children with appendicitis. The low negative appendectomy rates and the relationship between hospital volume and negative appendectomy rate suggest potential opportunities for improvement at the hospital level. Efforts to reduce the incidence of appendiceal rupture should focus on prehospital care. The findings of disparate care by race and health insurance status are troubling. A public health paradigm with concentration on access to care and quality-of-care issues as well as family and physician education might facilitate earlier diagnosis and intervention. The excessively high rates of appendiceal rupture in children should no longer be tolerated," the authors conclude.
(
JAMA. 2004;292:1977-1982. Available post-embargo at jama.com)

For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org

Go back to the top.


JAMA VIDEO NEWS REPORT

PSYCHOTHERAPY PLUS ANTI-DEPRESSANT BEST TREATMENT FOR KIDS WITH OBSESSIVE-COMPLUSIVE DISORDER

VIDEO:
B-ROLL
School kids, out of focus/no faces


AUDIO:
WHAT'S IT LIKE FOR A CHILD OR TEEN TO HAVE OBSESSIVE-COMPULSIVE DISORDER?

VIDEO:
SOT/FULL
@ :05
Super: John March, M.D., M.P.H.
Duke University Medical Center
Runs :17


AUDIO:
"For example, a child gets a funny feeling or fear that they're going to be contaminated if they touch a doorknob, get a bad illness, they'll give that illness to their mother and both of them will die. And so they avoid touching the doorknob and if they can't avoid it they go into the bathroom and wash their hands for 20 minutes to an hour."

VIDEO:
B-ROLL
School kids, out of focus/no faces


AUDIO:
THE KIDS KNOW THAT THE THOUGHTS AND THE COMPULSION TO WASH HANDS MAKE NO SENSE, BUT THEY ARE POWERLESS TO STOP. SO, MANY SEEK HELP.

VIDEO:
SOT/FULL
John March, M.D., M.P.H.
Duke University Medical Center
Runs :07


AUDIO:
"If you are a child or a parent and you go to the doctor, the thing you want to know is, at the end of treatment is my child going to be well."

VIDEO:
B-ROLL
Dr. March walking down hall
School kids, out of focus/no faces
Sertraline pills (pills only, no bottle)
GFX/JAMA COVER


AUDIO:
TO HELP ANSWER THAT QUESTION, DR. JOHN MARCH OF DUKE UNIVERSITY MEDICAL CENTER, WITH RESEARCHERS AT TWO OTHER UNIVERSITIES, SET OUT TO COMPARE TREATMENTS IN ABOUT ONE-HUNDRED KIDS, AGES SEVEN TO SEVENTEEN, WHO HAD O-C-D. THE TREATMENTS WERE COGNITIVE BEHAVIORAL THERAPY, OR C-B-T; SERTRALINE, AN ANTI-DEPRESSANT; A COMBINATION OF CBT AND SERTRALINE; AND FINALLY, PLACEBO, OR SUGAR PILL. THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

VIDEO:
SOT/FULL
John March, M.D., M.P.H.
Duke University Medical Center
Runs :08


AUDIO:
"The combination treatment was superior to cognitive behavioral psychotherapy alone, also superior to sertraline alone."

VIDEO:
Full Screen Graphic
Title: Kids no longer suffering from OCD
53.6% combination therapy
39.3% cognitive behavioral therapy
21.4% sertraline
3.6% placebo


AUDIO:
IN FACT, AFTER TWELVE WEEKS OF TREATMENT, MORE THAN HALF OF THE KIDS WHO RECEIVED THE COMBINATION TREATMENT NO LONGER SUFFERED FROM O-C-D. THAT FIGURE WENT DOWN TO ABOUT FORTY PERCENT FOR C-B-T ALONE, TWENTY-ONE PERCENT FOR SERTRALINE ALONE, AND LESS THAN FOUR PERCENT FOR PLACEBO.

VIDEO:
SOT/FULL
John March, M.D., M.P.H.
Duke University Medical Center
Runs :13


AUDIO:
"If you've got mild O-C-D and no other problems then you might want to start with CBT alone, but if you've got very severe OCD and it's been around for a long time and it's complicated for example by anxiety and depression then you might want to opt for the combination treatment."

VIDEO:
B-ROLL
School kids, no faces


AUDIO:
DR. MARCH SAYS PATIENTS, PARENTS AND PHYSICIANS NEED TO KNOW THAT COGNITIVE BEHAVIORAL THERAPY IS THE CRITICAL FIRST STEP IN TREATING O-C-D IN CHILDREN AND TEENS.
THIS IS MAVIS PRALL REPORTING.

HOME | EMBARGOED CONTENT | PAST ISSUES | EVENTS | HELP | SEARCH RELEASES
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.